Beta-Pinene

Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →

Chemical Class Bicyclic monoterpene (structural isomer of alpha-pinene)
Molecular Formula / CAS C₁₀H₁₆ · CAS 127-91-3
Primary Botanical Source(s) Boswellia serrata oleoresin (frankincense), Eucalyptus species, pine, rosemary, nutmeg/mace
Plant Part Oleoresin (frankincense); leaf oil (eucalyptus, rosemary); seed (nutmeg/mace)
Typical Content A secondary monoterpene of most frankincense chemotypes, typically present at lower concentration than alpha-pinene within the same essential oil
Solubility / Format Volatile, lipophilic monoterpene; carried in oil-soluble and essential-oil-type extract formats
Sourcing Status Product-live — genuine match via Herbuno’s frankincense oil-soluble extract line, as a co-occurring monoterpene alongside alpha-pinene
Buy from Herbuno Indian Frankincense Oil Soluble Extract

Name origin: Beta-pinene shares its name and pine-genus origin with its structural isomer alpha-pinene, distinguished by the position of a double bond within the same bicyclic monoterpene skeleton; the two compounds virtually always co-occur in the same essential oils, typically with alpha-pinene present at the higher concentration of the pair. Traditional use: As with alpha-pinene, beta-pinene has no independent traditional-use history separate from the resinous and aromatic plants that carry it — frankincense, eucalyptus, pine and rosemary each have long, separate traditional-medicine and ritual-use histories across Middle Eastern, Mediterranean, Australian Aboriginal and other traditions, predating any distinction between the two pinene isomers. Research trajectory: Beta-pinene research has largely proceeded alongside alpha-pinene as comparative isomer studies, and this comparative framing has produced one of the more useful findings in the pinene literature: beta-pinene is not simply a weaker version of alpha-pinene, but shows a distinct activity profile of its own in several assays, sometimes exceeding alpha-pinene and sometimes showing no activity where alpha-pinene is active. Commercial source: Frankincense (Boswellia serrata) oleoresin is a documented source of beta-pinene as a secondary monoterpene alongside alpha-pinene, both captured through the same oil-soluble extraction route.


Evidence for Beta-Pinene Applications

Beta-pinene co-occurs with alpha-pinene across the same major botanical sources — frankincense, pine, rosemary, cypress and juniper — typically at a lower relative concentration within a given essential oil, though the precise alpha-to-beta ratio varies considerably by species and chemotype. A comprehensive review of pinene pharmacology catalogues both isomers together as sharing a broad activity profile including anticoagulant, anti-inflammatory, antileishmanial, antimalarial, antimicrobial, antioxidant, antitumour and analgesic effects across the accumulated research literature (et al. 2021). Claim strength: Moderate.

In a direct rodent antinociceptive study, beta-pinene isolated from Eucalyptus camaldulensis leaf essential oil produced measurable pain-relieving effects at the supraspinal level specifically, and notably reversed the antinociceptive effect of morphine to a degree comparable with the opioid antagonist naloxone, leading researchers to propose that beta-pinene may act as a partial agonist at mu-opioid receptors based on structural and electrostatic similarities identified between the two molecules (Liapi et al. 2007). This is a distinctive, receptor-specific finding that differentiates beta-pinene mechanistically from a purely anti-inflammatory framing. Claim strength: Emerging.

Direct antimicrobial comparison of pinene isomers and enantiomers found that only the positive enantiomers of both alpha- and beta-pinene showed microbicidal activity against the bacteria and fungi tested, including methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans, with (+)-beta-pinene additionally showing synergistic activity when combined with the antibiotic ciprofloxacin against MRSA (da Silva et al. 2012). Negative enantiomers of both compounds showed no antimicrobial activity even at much higher concentrations, underscoring that enantiomeric purity, not just isomer identity, affects a given material’s bioactivity. Claim strength: Moderate.

Beta-pinene has also shown synergistic antitumour effects when combined with the chemotherapeutic agent paclitaxel against non-small-cell lung carcinoma cells in laboratory research, with evidence of increased apoptosis in the combination treatment relative to either compound alone. This remains an early-stage in-vitro finding and has not progressed to animal or human testing for oncology applications. Claim strength: Emerging.

A useful caution for formulators comes from the chondroprotective isomer-comparison research discussed on the alpha-pinene page: beta-pinene was found inactive in that specific IL-1beta-induced chondrocyte inflammation assay even as (+)-alpha-pinene showed the strongest activity of the isomers tested, illustrating that the two compounds cannot be assumed interchangeable across different biological targets and that claims should be matched to isomer-specific evidence rather than generalised “pinene” activity. Claim strength: Moderate.

Beta-pinene is a genuine, documented secondary monoterpene of frankincense oleoresin, co-occurring with alpha-pinene in the same essential-oil fraction. The Indian Frankincense Oil Soluble Extract is the appropriate Herbuno format for beta-pinene sourcing intent, delivered alongside alpha-pinene rather than as an isolated single-compound extract; formulators requiring a specific alpha-to-beta pinene ratio should request lot-specific GC-MS data.

Dosage & Formulator Specification

No beta-pinene-standardised commercial ingredient with an established human oral dosing range exists. Published pharmacological research has used isolated-compound doses in rodent studies typically in the tens of mg/kg range and in-vitro concentrations in the low-to-mid µM range, neither of which establishes a validated human supplemental dose.

Analytical quantification of beta-pinene follows the same GC-MS methodology used for alpha-pinene and other volatile monoterpenes; because the two isomers co-elute closely on some chromatographic methods and show materially different bioactivity in several assays, formulators should request a resolved alpha-pinene/beta-pinene breakdown rather than a combined “total pinene” figure.

As with alpha-pinene, beta-pinene’s volatility means oil-soluble and essential-oil-type extraction formats capture it more effectively than aqueous or standardised powder extraction, and evaporative loss during heat-processing or extended open-air handling should be accounted for in manufacturing process design.

Regulatory positioning for beta-pinene follows the same established frankincense, eucalyptus, pine and rosemary essential-oil precedent as alpha-pinene; it is a recognised flavouring and fragrance constituent with no beta-pinene-specific supplement dosing limit. Given the enantiomer- and isomer-specific bioactivity differences documented in the research, formulators should avoid extending alpha-pinene research findings to beta-pinene, or vice versa, without checking that the specific claim was tested for the isomer in question.


Frequently Asked Questions — Beta-Pinene

Is beta-pinene just a weaker version of alpha-pinene?

Not necessarily. While the two are structurally similar and often studied together, research has found they can differ meaningfully in specific assays — beta-pinene showed no activity in one chondroprotective inflammation study where alpha-pinene was the most potent compound tested, while beta-pinene showed distinct opioid-receptor-related antinociceptive activity that has not been reported for alpha-pinene in the same way.

Where does beta-pinene come from in Herbuno’s frankincense product?

Beta-pinene co-occurs with alpha-pinene as a secondary monoterpene within Boswellia serrata oleoresin essential oil, captured through the same oil-soluble extraction process used for the Indian Frankincense Oil Soluble Extract. The two compounds are not separated in this product; both are present as part of the natural monoterpene fraction.

What is the most distinctive research finding on beta-pinene specifically?

One of the more distinctive findings is a rodent study reporting that beta-pinene produced supraspinal pain-relieving effects and reversed morphine’s antinociceptive effect in a manner similar to the opioid antagonist naloxone, leading researchers to propose it may act as a partial agonist at mu-opioid receptors, distinct from the anti-inflammatory framing more commonly applied to alpha-pinene.

Can I request a specific alpha-pinene-to-beta-pinene ratio from Herbuno?

The alpha-to-beta pinene ratio in Herbuno’s frankincense oil-soluble extract reflects the natural composition of the Boswellia serrata oleoresin used and varies by chemotype and harvest lot. Formulators with a specific ratio requirement should contact Herbuno to request lot-specific GC-MS data before ordering.

Related compounds: Alpha-Pinene, Boswellic Acid

Claim-strength scale — High: multiple clinical or well-replicated human studies; Moderate: in-vitro, animal, or mechanistic evidence with traditional-use corroboration; Emerging: early-stage or preliminary research.
Zurück zum Blog

Einen Kommentar hinterlassen

Bitte beachten Sie, dass Kommentare vor der Veröffentlichung genehmigt werden müssen.